France· FR:69870854
GRANIONS DE SOUFRE 19,5 mg/2 ml, solution buvable
A medicinal product containing thiosulfate de sodium, registered in France by GRANIONS.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- THIOSULFATE DE SODIUM
- Manufacturer
- GRANIONS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093943877130 ampoule(s) en verre brun de 2 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Thiosulfate de sodium in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPedmarqsi 8g/100ml solution for infusion vialsNorgine Pharmaceuticals Ltd
- CanadaSEACALPHYXSEAFORD PHARMACEUTICALS INC
- BelgiumGammadyn SoufreUnda
- Japanチオ硫酸ナトリウム水和物
- United StatesPEDMARKFennec Pharmaceuticals Inc.
- CzechiaNATRIUMTHIOSULFAT 10%
- IrelandPedmarqsi 80 mg/mL solution for infusionNorgine B.V.
- NetherlandsNatriumthiosulfaat Hope 250 mg/ml, oplossing voor injectieHope Pharmaceuticals, Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Thiosulfate De Sodium Sterop
- Germany · Natriumthiosulfat
- United Kingdom (Northern Ireland) · Pedmarqsi, Sodium Thiosulfate Hope Pharmaceuticals
- Ireland · Sodium Thiosulfate Hope Pharmaceuticals
- Iceland · Pedmarqsi
- Italy · Sodio Tiosolfato Monico, Sodio Tiosolfato S.A.L.F.
- Liechtenstein · Pedmarqsi
- Luxembourg · Oligosol
- Netherlands · Natriumthiosulfaat Hope
- Norway · Pedmarqsi
- Sweden · Natriumtiosulfat Hope
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/49361c26-fba6-42c6-9a49-7277ce175913 GET /v1/drugs/49361c26-fba6-42c6-9a49-7277ce175913?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69870854",
"date_amm": "1998-01-26",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "THIOSULFATE DE SODIUM",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about thiosulfate de sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.